1. Short title This Act may be cited as the DXM Abuse Prevention Act of 2017 . 2. Sales of over-the-counter drugs containing dextromethorphan (a) Prohibited acts (1) Verification system Section 301 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 331 ) is amended by adding at the end the following: (eee) The failure of a retailer (as defined in section 506H) that offers for sale in interstate commerce covered drugs (as defined in section 506H) to have a verification system as required by section 506H (relating to sales of over-the-counter drugs containing dextromethorphan). . (2) Identifier for electronic point of sale system; active ingredients Section 301 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 331 ), as amended by paragraph (1), is further amended by adding at the end the following: (fff) The introduction or delivery for introduction into interstate commerce of any covered drug (as defined in section 506H) whose labeling does not include— (1) a universal product code, universal product number, bar code, or similar identifier to allow an electronic point of sale system to recognize that the sale of the covered drug is prohibited to those under the age of 18